Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/1998
05/14/1998WO1998009665A3 Iontophoretic method of using phenylephrine to improve the effect of local anesthetics
05/14/1998WO1998009647A3 Cyanidin compositions and therapeutic and diagnostic uses therefor
05/14/1998WO1998005776A3 Secreted proteins and polynucleotides encoding them
05/14/1998WO1998005291A3 Method for treating mental retardation
05/14/1998WO1998003182A3 Use of uridine triphosphates and related compounds for the prevention and treatment of pneumonia in immobilized patients
05/14/1998WO1998001440A3 Anti-viral pharmaceutical compositions containing saturated 1,2-dithiaheterocyclic compounds and uses thereof
05/14/1998WO1997048801A3 Polynucleotides encoding secreted proteins
05/14/1998WO1997044054A3 Type-2 chemokine binding proteins and methods of use therefor
05/14/1998WO1997041822A3 Anti-viral compounds
05/14/1998DE19646726A1 Topical composition containing polymeric quaternary ammonium salt
05/14/1998CA2593733A1 A method for treating tension-type headache
05/14/1998CA2271235A1 Glaucoma-associated protein and corresponding nucleic acid and their therapeutic and diagnostic uses
05/14/1998CA2271013A1 Nitric oxide donor compounds and pharmaceutical compositions for pulmonary hypertension and other indications
05/14/1998CA2271000A1 Composition and method for the treatment of vaginal yeast infections
05/14/1998CA2270973A1 New knoevenagel condensation products, method for their production and their use
05/14/1998CA2270966A1 1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as hiv protease inhibitors
05/14/1998CA2270963A1 (4r,5s,6s,7r)-hexahydro-1- [5-(3-aminoinazole)methyl] -3-butyl-5,6-dihydroxy-4,7-bis [phaenylmethyl] -2h-1,3-diazepin-2-one, its preparation and its use as hiv protease inhibitor
05/14/1998CA2270780A1 Method for treating alzheimer's disease
05/14/1998CA2270775A1 Improved intraocular irrigating solution containing a polyamine antagonist
05/14/1998CA2270561A1 Synergistic gold-containing compositions
05/14/1998CA2270545A1 Substituted 3-benzylpyrazoles and their use as herbicides and for lowering the sugar content in blood
05/14/1998CA2270520A1 Chewing gum containing colloidal bismuth subcitrate
05/14/1998CA2270355A1 Cyclopentylxanthine derivatives for use in the treatment of cystic fibrosis
05/14/1998CA2270349A1 Use of a combination of carbonic anhydrase inhibitors and prostaglandins for treating glaucoma
05/14/1998CA2270293A1 Fatty-acid amide hydrolase
05/14/1998CA2270171A1 Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines
05/14/1998CA2270153A1 Methods for identifying genes essential to the growth of an organism
05/14/1998CA2270137A1 Stabilized transient gene expression
05/14/1998CA2270118A1 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
05/14/1998CA2269858A1 Substituted oximes, hydrazones and olefins as neurokinin antagonists
05/14/1998CA2269838A1 Method for treatment of glutamate related disorders
05/14/1998CA2269647A1 Human squalene epoxidase
05/14/1998CA2269646A1 Diabetes-mediating proteins and therapeutic uses thereof
05/14/1998CA2268126A1 Quinolines and their therapeutic use
05/14/1998CA2263429A1 Dihydropyrones with improved antiviral activity
05/14/1998CA2263301A1 Isoquinolones
05/14/1998CA2247410A1 Method for enhancing the solubility of substantially water-insoluble compounds
05/14/1998CA2241896A1 Sustained release formulation containing dfmo
05/14/1998CA2239463A1 Nucleotide sequences that encode phosphatidylinositol-3' kinase associated proteins and uses thereof
05/13/1998EP0841396A1 Human telomerase catalytic subunit
05/13/1998EP0841394A2 Staphylococcus aureus polynucleotides, polypeptides and their uses
05/13/1998EP0841341A1 Sunscreen agents, and cosmetic compositions containing them
05/13/1998EP0841339A1 Vinylpyrrolidinon cephalosporin derivatives
05/13/1998EP0841337A1 Substituted 7,12-dioxabenzo(a)anthracene derivatives, process for their preparation and pharmaceutical compositions containing them
05/13/1998EP0841330A1 Aminomethyl heterocyclic derivatives, process of their preparation and pharmaceutical compositions containing them
05/13/1998EP0841327A1 Triazole antifungal agent
05/13/1998EP0841064A1 Use of bactericidal/permeability increasing protein or biologically active analogs thereof to treat lipopolysaccharide associated gram negative infections
05/13/1998EP0841057A2 Phospholipid composition, method of making it and its use
05/13/1998EP0841011A1 Dietary preparation comprising chitosan and other soluble fibres combined with ascorbic acid, organic chromium, vanadium and garcinia hydroxycitrate for lipid absorption lowering and glucide metabolism stabilization
05/13/1998EP0841010A1 Stable compositions dispersible in cold water
05/13/1998EP0840801A2 Methods and compositions for identifying morphogen analogs
05/13/1998EP0840796A2 Mucosal delivery of polynucleotides
05/13/1998EP0840789A2 Transketolase-related protein
05/13/1998EP0840750A1 Ha-2 antigenic peptide
05/13/1998EP0840749A1 The h-y antigen
05/13/1998EP0840747A1 Papillomavirus polyprotein constructs
05/13/1998EP0840744A1 Phosphonic acid-based cationic lipids
05/13/1998EP0840743A1 Therapeutic oligonucleotides targeting the human mdr1 and mrp genes
05/13/1998EP0840741A1 Pna-dna chimeras and pna synthons for their preparation
05/13/1998EP0840740A1 New inhibitors of platelet aggregation
05/13/1998EP0840739A1 High affinity nucleic acid ligands to lectins
05/13/1998EP0840738A1 Colchicine derivatives, the use thereof and formulations containing them
05/13/1998EP0840737A1 Triterpenes
05/13/1998EP0840735A1 Resolution of 1-azabicyclo 2.2.2]octan-3-amine, 2-(diphenylmethyl)-n- 2-methoxy-5-(1-methylethyl)phenyl]methyl]
05/13/1998EP0840733A1 A triazolylmethyl-indole ethylamine bisulfate salt
05/13/1998EP0840732A1 Substituted benzolactam compounds as substance p antagonists
05/13/1998EP0840731A1 Polycyclic alcaloid-derivatives as nmda-receptor antagonists
05/13/1998EP0840729A1 Inhibitors of phospholipase a 2?
05/13/1998EP0840728A1 Heteroaryl diol acids as leukotriene antagonists
05/13/1998EP0840727A1 3-hydroxy-2(1h)-pyridinone chelating agents
05/13/1998EP0840725A1 Azetidinone derivatives for the treatment of atherosclerosis
05/13/1998EP0840622A1 Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity
05/13/1998EP0840621A1 Hormone patch
05/13/1998EP0840620A1 Il-8 antagonists for treatment of inflammatory disorders and asthma
05/13/1998EP0840616A1 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological disease
05/13/1998EP0840613A1 Synergistic pharmaceutical compositions containing triamcinolone acetonide and halcinonide
05/13/1998EP0840612A1 Inhibition of nmda receptor activity by pregnenolone sulfate derivatives
05/13/1998EP0840611A1 Oral acyclovir delivery
05/13/1998EP0840610A1 Composition comprising d-threo-methylphenidate and another drug
05/13/1998EP0840609A1 Use of unsubstituted and substituted n-(pyrrol-1-yl)pyridinamines as anticonvulsant agents
05/13/1998EP0840608A1 Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles
05/13/1998EP0840607A1 Novel medical use
05/13/1998EP0840606A1 Di- and trivalent small molecule selectin inhibitors
05/13/1998EP0840605A1 Compounds useful in the treatment of neurofibromatosis
05/13/1998EP0840604A1 Non-beta-oxidizable fatty acid analogues, their uses as therapeutic active medicaments, and preparation thereof
05/13/1998EP0840603A1 Pharmaceutical composition of l-dopa ethyl ester
05/13/1998EP0840602A1 Use of a retinoid for preparing an antibacterial drug
05/13/1998EP0840601A1 Non-allosteric gaba-a agonists for treating sleep disorders
05/13/1998EP0840600A1 Transdermal patch containing aspirin
05/13/1998EP0840599A1 Pharmaceutical compositions of conjugated estrogens and methods for their use
05/13/1998EP0840575A1 Angiogenic lipid formulations
05/13/1998EP0688222B1 Therapeutic compositions containing a lithium compound and silica
05/13/1998EP0662971B1 5H,10H-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE-4-ONE DERIVATIVES, PREPARATION THEREOF AND MEDICAMENTS CONTAINING THEM
05/13/1998EP0660707A4 Method of preventing nmda receptor-mediated neuronal damage.
05/13/1998EP0641770B1 Novel compound with platelet aggregation inhibitor activity
05/13/1998EP0628032B1 Quinazolinone antianginal agents
05/13/1998EP0623118B1 Carbamate derivatives and their use in medicine
05/13/1998EP0606382B1 1,8-benzonaphthyridine derivatives and antimicrobial compositions
05/13/1998EP0606376B1 Method for genetically modifying bone marrow cells of primates, and useful cells therefor that produce recombinant retroviral vectors
05/13/1998EP0599881B1 Gallium (iii) complexes, process for their obtention and pharmaceutical compositions containing them
1 ... 6655 6656 6657 6658 6659 6660 6661 6662 6663 6664 6665 6666 6667 6668 6669 6670 6671 6672 6673 6674 6675 ... 7860